propranolol has been researched along with Experimental Hepatoma in 11 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propranolol is a lipophilic non-selective beta-blocker mainly eliminated via the liver; atenolol is a hydrophilic beta 1-selective blocking agent, mainly eliminated via the kidney." | 1.29 | Evaluation of the tumor-promoting activity of two beta-adrenoreceptor blocking agents, propranolol and atenolol, in liver of Fischer 344 rats. ( Ameri, L; Arias, E; Girotti, P; Mazzoleni, G; Presta, M; Radaelli, G; Ragnotti, G; Zavanella, T, 1994) |
| " Vasoactive drugs may therefore be of value to diminish adverse side effects of the combination cytostatic agent + DSM, probably decreasing overspill into normal tissues." | 1.28 | Reduction by norepinephrine of the side effects induced by combined hepatic arterial administration of degradable strach microspheres and adriamycin in rats with a liver adenocarcinoma. ( Jakobsson, B; Roos, G; Stenram, U; Teder, H, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (63.64) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsunaga, T | 2 |
| Takemoto, N | 1 |
| Miyamoto, K | 2 |
| Koshiura, R | 2 |
| Iwasaki, M | 1 |
| Presta, M | 2 |
| Zavanella, T | 2 |
| Mazzocchi, C | 1 |
| Ziliani, S | 1 |
| Mazzoleni, G | 2 |
| Calovini, D | 1 |
| Braga, M | 1 |
| Ragnotti, G | 2 |
| Ackerman, NB | 2 |
| Makohon, S | 1 |
| Ming, M | 1 |
| Wu, J | 1 |
| Lachance, S | 1 |
| Delalandre, A | 1 |
| Carrière, S | 1 |
| Chan, JS | 1 |
| Radaelli, G | 1 |
| Girotti, P | 1 |
| Arias, E | 1 |
| Ameri, L | 1 |
| Steiner, A | 1 |
| Walle, T | 1 |
| Jakobsson, B | 1 |
| Teder, H | 1 |
| Roos, G | 1 |
| Stenram, U | 1 |
| Cortinovis, C | 1 |
| Mayer, D | 1 |
| Bouscarel, B | 1 |
| Paris, H | 1 |
| Murat, JC | 1 |
| Jacobs, R | 1 |
| Bloom, ND | 1 |
| Poon, TT | 1 |
| Burton, MA | 1 |
| Gray, BN | 1 |
11 other studies available for propranolol and Experimental Hepatoma
| Article | Year |
|---|---|
Studies on responsiveness of hepatoma cells to catecholamines. I. Lack of beta-adrenergic responsiveness in rat ascites hepatoma AH13 cells.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclases; Animals; Binding Sites; Catecholamines; Cell | 1984 |
Relationship between enhancement of cytotoxic effect of mitomycin C and increase of intracellular cyclic adenosine 3':5'-monophosphate by isoproterenol in rat ascites hepatoma cells.
Topics: Animals; Bucladesine; Cell Survival; Cells, Cultured; Cyclic AMP; Female; Isoproterenol; Liver Neopl | 1983 |
Thyroid and chemical hepatocarcinogenesis: further insights from the hepatocarcinogen ZAMI 1305.
Topics: Animals; Carcinogens; Female; Hyperplasia; Liver Neoplasms, Experimental; Male; Organ Size; Propanol | 1984 |
The blood supply of experimental liver metastases. VII. Further studies on increased tumor vascularity caused by epinephrine.
Topics: Animals; Carcinoma 256, Walker; Epinephrine; Liver Neoplasms; Liver Neoplasms, Experimental; Microci | 1984 |
Beta-adrenergic receptors and angiotensinogen gene expression in mouse hepatoma cells in vitro.
Topics: Angiotensin II; Angiotensinogen; Animals; Cyclic AMP-Dependent Protein Kinases; Dexamethasone; Gene | 1995 |
Evaluation of the tumor-promoting activity of two beta-adrenoreceptor blocking agents, propranolol and atenolol, in liver of Fischer 344 rats.
Topics: Animals; Atenolol; Body Weight; Carcinogens; Diethylnitrosamine; Female; gamma-Glutamyltransferase; | 1994 |
Potent inhibition of MAO mediated propranolol metabolism by dimethyl sulfoxide in Hep G2 cells.
Topics: Animals; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dimethyl Sulfoxide; Hum | 1992 |
Reduction by norepinephrine of the side effects induced by combined hepatic arterial administration of degradable strach microspheres and adriamycin in rats with a liver adenocarcinoma.
Topics: Adenocarcinoma; Animals; Doxorubicin; Hepatic Artery; Injections, Intra-Arterial; Liver; Liver Neopl | 1991 |
Study of beta-adrenoceptors and beta-adrenergic responsiveness in cultured "preneoplastic-like" and neoplastic rat hepatocytes.
Topics: 1-Methyl-3-isobutylxanthine; Adrenergic beta-Antagonists; Albuterol; Animals; Atenolol; Binding, Com | 1985 |
Increased capillary flow in intrahepatic tumors due to alpha-adrenergic effects of catecholamines.
Topics: Animals; Carcinoma 256, Walker; Epinephrine; Female; Isoproterenol; Liver Circulation; Liver Neoplas | 1988 |
Redistribution of blood flow in experimental hepatic tumours with noradrenaline and propranolol.
Topics: Animals; Drug Combinations; Drug Synergism; Liver Circulation; Liver Neoplasms, Experimental; Micros | 1987 |